NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Tata Chemicals FY26 Revenue at ₹14,584 Cr; Reports ₹1,837 Cr US Goodwill Impairment
Tata Chemicals reported a challenging FY26 with consolidated revenue dipping 2% to ₹14,584 crore, primarily due to lower global soda ash realizations. The company recognized a massive one-time impairment charge of ₹1,837 crore related to its US operations, leading to a significant reported loss for the quarter. Despite these headwinds, the India business showed resilience with higher volumes, and non-soda ash revenue grew by 14% to ₹6,946 crore. The board has recommended a dividend of ₹11 per share, while net debt increased to ₹5,961 crore due to unfavorable market conditions and currency depreciation.
முக்கிய அம்சங்கள்
Consolidated FY26 EBITDA fell 8% to ₹1,805 Cr due to unremunerative export prices in the US and SE Asia.Recognized a major exceptional impairment charge of ₹1,837 Cr on US goodwill and ₹182 Cr deferred tax asset write-off.Non-soda ash revenue increased 14% YoY to ₹6,946 Cr, reflecting a strategic shift toward non-cyclical segments.Mithapur facility reached a production milestone of 1 MTPA Soda Ash; Board recommended ₹11 per share dividend.Net debt rose to ₹5,961 Cr as of March 2026, though debt-to-equity remains healthy at 0.36.
👀 கவனிக்க வேண்டியவை
Investors should remain cautious as global soda ash pricing remains under pressure, though the company's focus on non-soda ash growth and India's volume strength provides some cushion. Monitor the recovery in US margins and the progress of upcoming capacity expansions in Mithapur and Cuddalore.
Tata Chemicals Approves ₹100 Crore Investment to Expand Salt Capacity at Mithapur
Tata Chemicals' Board has approved a ₹100 crore investment for debottlenecking its Iodised Vacuum Salt Dried (IVSD) capacity at the Mithapur plant. The project aims to add 82,500 TPA to the existing 1.60 MTPA capacity, addressing the high current utilization rate of 92%. This expansion is intended to meet growing market demand and is expected to be completed within the next 12 months. The investment will be funded through internal accruals and other financing options.
முக்கிய அம்சங்கள்
Investment of ₹100 crore approved for debottlenecking salt capacity at MithapurCapacity addition of 82,500 TPA to the existing 1.60 MTPA baseCurrent capacity utilization stands at a high 92%, necessitating the expansionProject completion timeline set for the next 12 monthsFunding to be managed through internal accruals and other options
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive move to protect and grow market share in the salt segment. Monitor the execution timeline over the next year for potential revenue impact in the consumer products division.
Tata Chemicals Recommends ₹11 Dividend per Share for FY 2025-26
Tata Chemicals has recommended a final dividend of ₹11 per equity share (110%) for the financial year ended March 31, 2026. While the dividend offers a payout to shareholders, the company's consolidated financial results reveal a significant net loss of ₹3,831 crores for the year on a total revenue of ₹7,049 crores. The group's total assets are reported at ₹22,500 crores, and the dividend remains subject to approval at the upcoming 87th Annual General Meeting. Investors should note the sharp contrast between the dividend declaration and the reported consolidated loss.
முக்கிய அம்சங்கள்
Board recommended a final dividend of ₹11 per equity share (110% of face value) for FY 2025-26.Consolidated total revenue for the financial year stood at ₹7,049 crores.Reported a substantial consolidated net loss after tax of ₹3,831 crores for the full year.Total consolidated assets as of March 31, 2026, were valued at ₹22,500 crores.Statutory auditors BSR & Co. LLP issued an unmodified opinion on the financial results.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the dividend is being paid despite a massive consolidated net loss of ₹3,831 crores. It is critical to investigate the specific drivers of this loss, likely stemming from international subsidiaries, before committing further capital.
Tata Chemicals Recommends ₹11 Dividend Despite ₹3,831 Crore Loss in Subsidiaries for FY26
Tata Chemicals has recommended a dividend of ₹11 per share (110%) for the financial year ended March 31, 2026, subject to shareholder approval. The consolidated financial results for the year were significantly impacted by a net loss of ₹3,831 crores from its 10 audited subsidiaries, despite these units generating ₹7,049 crores in revenue. Joint ventures provided a small cushion with a profit contribution of ₹167 crores. The statutory auditors have issued an unmodified opinion on the financial statements, ensuring reporting reliability despite the bottom-line pressure.
முக்கிய அம்சங்கள்
Recommended a dividend of ₹11 per share (110%) for the financial year 2025-26.Subsidiaries reported a substantial combined net loss of ₹3,831 crores for the fiscal year.Total revenue from audited subsidiaries stood at ₹7,049 crores with total assets of ₹22,500 crores.Joint ventures contributed a net profit of ₹167 crores and total comprehensive income of ₹186 crores.Statutory auditors BSR & Co. LLP issued an unmodified opinion on both standalone and consolidated results.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution and scrutinize the nature of the ₹3,831 crore subsidiary loss to see if it involves one-time impairments or structural operational issues. While the ₹11 dividend offers a yield, the significant consolidated loss may weigh on stock performance in the short term.
Tata Chemicals Mithapur Facility Hits 1 Million Tonne Soda Ash Production Milestone in FY26
Tata Chemicals has announced that its Mithapur facility in Gujarat achieved a significant operational milestone by producing 1 million tonnes of soda ash in FY 2025-26. This achievement highlights the company's operational rigour, plant efficiency, and reliability across its manufacturing functions. The management noted that this scale-up is a result of disciplined execution and a focus on asset productivity. From a financial perspective, this milestone is expected to support cost optimization and margin resilience in a competitive global environment.
முக்கிய அம்சங்கள்
Mithapur facility achieved 1 million tonnes of soda ash production milestone in FY 2025-26.Management attributes the success to operational rigour, plant efficiency, and cross-functional collaboration.CFO highlights focus on cost optimization and asset productivity to enhance margins.The milestone strengthens Tata Chemicals' competitive position in the global soda ash industry.The facility serves critical sectors including glass, detergents, and industrial chemicals.
👀 கவனிக்க வேண்டியவை
Investors should take this as a positive indicator of high capacity utilization and operational efficiency at the company's primary facility. Monitor upcoming quarterly results to see how this production volume impacts bottom-line margins and market share.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Tata Chemicals Completes 100% Acquisition of Novabay Pte. Limited
Tata Chemicals Limited, through its wholly owned subsidiary Tata Chemicals International Pte. Limited (TCIPL), has successfully completed the acquisition of 100% equity share capital of Novabay Pte. Limited on March 19, 2026. This follows the initial agreement signed on December 19, 2025, after all conditions precedent were met. The acquisition marks a significant step in the company's international expansion strategy. Investors should note that Novabay is now a step-down subsidiary of the company.
முக்கிய அம்சங்கள்
Completed 100% equity acquisition of Novabay Pte. Limited via subsidiary TCIPLTransaction finalized on March 19, 2026, following the December 2025 agreementAll conditions precedent specified in the Share Purchase Agreement have been fulfilledNovabay Pte. Limited becomes a step-down subsidiary of Tata Chemicals Limited
👀 கவனிக்க வேண்டியவை
Investors should monitor upcoming quarterly earnings to assess the financial contribution and synergy benefits of this acquisition. The stock remains a watch for long-term growth in the specialty chemicals space.
Tata Chemicals Q3FY26: Consolidated PAT Slips to -INR 15 Cr Amid Global Soda Ash Pricing Pressure
Tata Chemicals reported a consolidated EBITDA of INR 345 crores, down from INR 434 crores YoY, primarily due to sharp margin erosion in its US operations. While standalone India operations remained resilient with a 21% growth in PAT (before exceptional items) to INR 87 crores, global oversupply and a 54% drop in Chinese soda ash prices over three years have severely impacted realizations. The company is shifting focus toward value-added products, announcing over INR 1,400 crores in new CAPEX for salt, silica, and ash expansions in India. Net debt stands at INR 5,596 crores as the company navigates a challenging pricing cycle by pausing low-margin export volumes.
முக்கிய அம்சங்கள்
Consolidated EBITDA fell to INR 345 crores from INR 434 crores YoY due to weak US export realizations.Standalone India PAT before exceptional items grew 21% YoY to INR 87 crores supported by higher volumes.Board approved INR 515 crore for a 210 KTPA salt facility and INR 775 crore for silica expansion.Chinese soda ash prices plummeted 54% over the last three years to approximately CNY 1,200.Acquisition of Novabay Singapore completed to strengthen the premium bicarbonate market footprint.
👀 கவனிக்க வேண்டியவை
Investors should remain cautious as global soda ash oversupply is expected to persist, keeping realizations under pressure in the near term. Monitor the progress of India-centric CAPEX and the stabilization of UK operations for signs of a margin turnaround.
Fitch Affirms Tata Chemicals' Credit Rating at BB+ with Stable Outlook
Fitch Ratings has reaffirmed Tata Chemicals Limited's Long Term Foreign Currency Issuer Default Rating (IDR) at BB+ with a Stable outlook. The affirmation, announced on February 6, 2026, follows a review under Fitch's updated Corporate Rating Criteria. This rating indicates a steady credit profile for the company despite the sub-investment grade status. The stable outlook suggests that the rating is unlikely to face immediate downward pressure.
முக்கிய அம்சங்கள்
Fitch Ratings affirms Long Term Foreign Currency Issuer Default Rating at BB+The credit outlook for Tata Chemicals is maintained as StableThe rating action follows an update to Fitch's Corporate Rating CriteriaDisclosure made in compliance with Regulation 30(6) of SEBI LODR Regulations
👀 கவனிக்க வேண்டியவை
No immediate action is required as the credit rating remains unchanged. Investors should continue to monitor the company's debt levels and global soda ash pricing which influence its credit profile.
Tata Chemicals to invest ₹515 crore in new 210 KTPA salt facility in Tamil Nadu
Tata Chemicals has announced a ₹515 crore investment to set up a greenfield Iodised Vacuum Salt Dried (IVSD) facility in Tamil Nadu. The plant will have an annual capacity of 210 KTPA and is expected to be operational within 36 months. This project marks the company's first major salt manufacturing site outside Gujarat, where it currently operates a 1.6 million tonne facility. The expansion is strategically aimed at reducing logistics costs and strengthening the supply chain for southern Indian markets.
முக்கிய அம்சங்கள்
Investment of ₹515 crore for a 210 KTPA greenfield salt manufacturing facility in Tamil NaduProject to be completed within 36 months using internal accruals or external debtDiversifies production base beyond the existing 1.6 million tonne plant in Mithapur, GujaratAims to optimize logistics and transit times for the South Indian market
👀 கவனிக்க வேண்டியவை
Investors should monitor the project's execution over the next three years as it strengthens the company's market leadership in the salt segment. The geographical diversification is a positive step for long-term margin improvement through logistics savings.
Tata Chemicals to Invest ₹515 Crore for 210 KTPA Salt Facility in Tamil Nadu
Tata Chemicals has approved a ₹515 crore investment to set up a greenfield manufacturing facility in Valinokkam, Tamil Nadu. The plant will produce 210 KTPA of Iodised Vacuum Salt Dried (IVSD) and is expected to be completed within 36 months. This strategic expansion creates a second manufacturing hub for salt, complementing the existing 1.6 million tonnes per annum capacity at Mithapur, Gujarat. The move is aimed at optimizing logistics costs and improving supply chain efficiency for the South Indian market.
முக்கிய அம்சங்கள்
Investment of ₹515 crore for a greenfield IVSD manufacturing facility in Tamil NaduNew capacity of 210 KTPA to be added to the existing 1.6 MTPA salt production baseProject completion timeline estimated at 36 months from February 2026Strategic rationale includes reducing logistic costs and creating a second manufacturing siteFunding to be sourced through a mix of internal accruals and external financing
👀 கவனிக்க வேண்டியவை
Investors should monitor the project's execution over the next three years as it strengthens the company's market position in South India. The focus on logistics optimization is a positive sign for long-term margin improvement in the salt segment.
Tata Chemicals Q3 FY26: EBITDA Drops 21% to ₹345 Cr Amid Weak Global Soda Ash Pricing
Tata Chemicals reported a weak Q3 FY26 performance with consolidated revenue at ₹3,550 crore and EBITDA falling 21% YoY to ₹345 crore. The bottom line turned into a loss of ₹15 crore (before exceptional items) due to significantly lower soda ash realizations globally, despite higher sales volumes in India. Net debt increased to ₹5,596 crore from ₹4,884 crore in March 2025, impacted by lower cash generation and currency depreciation. The company is focusing on cost management and specialty chemicals to offset the cyclical downturn in its core soda ash business.
முக்கிய அம்சங்கள்
Consolidated EBITDA fell 21% YoY to ₹345 Cr as lower realizations offset volume growth.Reported a PAT loss of ₹15 Cr (before exceptional items) vs a profit of ₹49 Cr in Q3 FY25.Net debt rose to ₹5,596 Cr, with a debt-to-equity ratio maintained at a healthy 0.31x.Soda ash demand remains flat globally with high inventories keeping prices near record lows.Commissioned new capacities in Silica (3,000 MTPA) and FOS (4,500 MTPA) during the quarter.
👀 கவனிக்க வேண்டியவை
The stock may face near-term pressure due to weak global pricing and earnings contraction. Long-term investors should track the recovery in soda ash demand and the scaling of new specialty chemical capacities.
Tata Chemicals Q3 Results: Consolidated PAT Slips to Loss; ₹515 Cr Salt Plant Investment Approved
Tata Chemicals reported a weak consolidated performance for Q3FY26, with revenue dipping 1% YoY to ₹3,550 crore and EBITDA falling 20.5% to ₹345 crore due to global soda ash oversupply. The company posted a consolidated loss of ₹15 crore (before exceptional items) compared to a profit of ₹49 crore in the previous year. Despite global headwinds, the standalone India business showed resilience with a 21% growth in PAT before exceptional items. To drive future growth, the Board approved a ₹515 crore greenfield investment for a 210 KTPA salt facility in Tamil Nadu.
முக்கிய அம்சங்கள்
Consolidated EBITDA declined to ₹345 Cr from ₹434 Cr YoY due to pricing pressure in export markets, especially Southeast Asia.Standalone PAT (before exceptional items) rose 21% to ₹87 Cr, supported by higher volumes and disciplined cost management.Board approved ₹515 Cr investment for a 210 KTPA greenfield Iodised Vacuum Salt facility in Tamil Nadu.Net debt stood at ₹5,596 Cr as of December 31, 2025, excluding lease liabilities of ₹772 Cr.Exceptional charge of ₹54 Cr (consolidated) and ₹14 Cr (standalone) provided for the new labour code.
👀 கவனிக்க வேண்டியவை
Investors should exercise caution as the global soda ash market remains oversupplied with limited near-term visibility on price recovery. While the standalone India business is resilient, the consolidated performance remains under pressure from international pricing dynamics.
Tata Chemicals Q3 FY26 Net Loss Widens to ₹69 Crore as Revenue Declines to ₹3,550 Crore
Tata Chemicals reported a consolidated net loss of ₹69 crore for Q3 FY26, widening from a loss of ₹21 crore in the same quarter last year. Revenue from operations saw a marginal decline of 1.1% YoY to ₹3,550 crore, while falling 8.4% on a sequential basis. The bottom line was impacted by higher raw material and freight costs, alongside an exceptional loss of ₹54 crore. However, a significant fair value gain on equity investments led to a positive total comprehensive income of ₹884 crore for the period.
முக்கிய அம்சங்கள்
Revenue from operations fell to ₹3,550 crore from ₹3,590 crore in the year-ago period.Net loss attributable to equity shareholders widened to ₹93 crore from ₹53 crore YoY.Freight and forwarding expenses rose 18.9% YoY to ₹767 crore.Power and fuel costs dropped significantly to ₹444 crore from ₹690 crore YoY, providing some relief.EPS for the quarter stood at negative ₹3.65 compared to negative ₹2.08 in Q3 FY25.
👀 கவனிக்க வேண்டியவை
The widening operational loss and rising logistics costs are concerning; investors should wait for signs of margin stabilization in the chemical segment. Monitor global soda ash pricing and demand trends closely as they remain the primary drivers for the company's recovery.
Tata Chemicals to Acquire Singapore's Novabay for EUR 25 Million to Boost Specialty Bicarb Portfolio
Tata Chemicals' subsidiary, TCIPL, has signed a deal to acquire 100% of Novabay Pte. Limited for an enterprise value of EUR 25 million (~SGD 37.8 million). Novabay is a Singapore-based manufacturer of premium-grade sodium bicarbonate with a 60,000-ton capacity, serving high-margin sectors like Pharma and Food. This strategic move aims to shift the company's mix toward non-cyclical, high-value products. The acquisition is expected to be completed by March 2026 and offers a clear path to expand capacity to 100,000 tons.
முக்கிய அம்சங்கள்
Acquisition of 100% stake in Novabay at an enterprise value of EUR 25 million in an all-cash deal.Novabay reported a CY24 turnover of SGD 29.49 million, showing growth from SGD 25.93 million in CY23.Current production capacity of 60,000 tons with potential to scale up to 100,000 tons.Target entity holds key cGMP and API certifications for pharmaceutical and hemodialysis applications.Strategic alignment with Tata Chemicals' goal to expand in high-value, non-cyclical specialty chemical segments.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive strategic pivot toward high-margin specialty chemicals which reduces reliance on cyclical industrial soda ash. Monitor the execution of the capacity expansion and its impact on consolidated EBITDA margins post-2026.
Tata Chemicals Allots ₹1,500 Crore NCDs at 7.06% Coupon Rate
Tata Chemicals has successfully completed the allotment of 1,50,000 Non-Convertible Debentures (NCDs) to raise ₹1,500 crore on a private placement basis. These unsecured, rated debentures carry a fixed coupon rate of 7.06% per annum, which is competitive for the current market. The instruments have a tenor of 2 years and 364 days and will be listed on the NSE Debt Segment. This move strengthens the company's liquidity position and likely supports refinancing or general corporate purposes.
முக்கிய அம்சங்கள்
Allotment of 1,50,000 NCDs with a face value of ₹1,00,000 eachTotal capital raised aggregates to ₹1,500 crore via private placementFixed coupon rate set at 7.06% with a tenor of 2 years 364 daysNCDs are unsecured, rated, and redeemable, to be listed on NSE Debt Segment
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine treasury management activity that leverages the company's strong credit profile to secure low-cost debt. No immediate action is required, but monitor the company's overall leverage ratios in upcoming quarterly results.
Tata Chemicals to Raise ₹1,500 Crore via Private Placement of NCDs
Tata Chemicals has finalized the terms for raising ₹1,500 crore through the issuance of 1,50,000 unsecured Non-Convertible Debentures (NCDs). These NCDs, with a face value of ₹1,00,000 each, will be issued on a private placement basis and listed on the NSE debt segment. The tenure is fixed at 2 years and 364 days with a bullet repayment at maturity. The issue has been assigned a high credit rating of 'AA+/Stable' by both CARE and CRISIL, reflecting strong financial stability.
முக்கிய அம்சங்கள்
Total fundraise of ₹1,500 crore through 1,50,000 NCDs of ₹1,00,000 face value eachInstrument rated 'AA+/Stable' by both CARE Ratings and CRISIL RatingsTenure of 2 years 364 days with a bullet repayment structure at maturityFixed rate coupon to be determined via bidding on the NSE Electronic Bidding PlatformNCDs are unsecured, taxable, and will be listed on the NSE Debt Segment
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine capital management exercise supported by strong credit ratings. Monitor the final coupon rate discovered during bidding to assess the company's cost of debt relative to industry peers.
CRISIL has assigned a 'Crisil AA+/ Stable' rating to Tata Chemicals' ₹1,200 crore Non-Convertible Debentures (NCDs). It has also re-affirmed the 'Crisil AA+/ Stable' rating for ₹1,700 crore NCDs and 'Crisil A1+' rating for ₹300 crore Commercial Paper. These ratings indicate a stable outlook for the company's debt instruments. Investors should note these ratings as they reflect the creditworthiness of Tata Chemicals.
முக்கிய அம்சங்கள்
Crisil assigned 'Crisil AA+/ Stable' rating to ₹1,200 crore NCDsCrisil re-affirmed 'Crisil AA+/ Stable' rating to ₹1,700 crore NCDsCrisil re-affirmed 'Crisil A1+' rating to ₹300 crore Commercial Paper
👀 கவனிக்க வேண்டியவை
Investors should monitor Tata Chemicals' financial performance and any changes to these credit ratings. The stable outlook suggests continued financial stability.
CARE reaffirms Tata Chemicals' ₹1,700 crore NCD rating at AA+; Stable
CARE Ratings has reaffirmed the credit ratings for Tata Chemicals Limited. The rating for Non-Convertible Debentures (NCDs) worth ₹1,700 crore is reaffirmed at CARE AA+; Stable. Long Term Bank Facilities worth ₹1,300 crore also have a reaffirmed rating of CARE AA+; Stable. Short Term Bank Facilities worth ₹2,000 crore retain the CARE A1+ rating. A new Non-Convertible Debenture (NCD) of ₹1,500 crore has been assigned a CARE AA+; Stable rating.
முக்கிய அம்சங்கள்
₹1,700 crore NCDs reaffirmed at CARE AA+; Stable₹1,300 crore Long Term Bank Facilities reaffirmed at CARE AA+; Stable₹2,000 crore Short Term Bank Facilities reaffirmed at CARE A1+₹1,500 crore NCDs assigned CARE AA+; Stable
👀 கவனிக்க வேண்டியவை
The reaffirmed credit ratings indicate stable financial health for Tata Chemicals. Investors should monitor the company's performance and any changes in these ratings for future investment decisions.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
